Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 4
1998 3
1999 7
2000 3
2001 1
2002 1
2003 8
2004 4
2005 7
2007 1
2008 1
2009 3
2010 11
2011 13
2012 11
2013 21
2014 17
2015 9
2016 10
2017 10
2018 14
2019 15
2020 13
2021 5
2022 3
2023 17
2024 8
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hutterli m[au] (16 results)?
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger HL, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph DJ, Tobias JS. Vaidya JS, et al. Among authors: sutterlin m. BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836. BMJ. 2020. PMID: 32816842 Free PMC article. Clinical Trial.
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Gass P, Lück HJ, Hein A, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Huebner H, Goossens C, Brucker SY, Hack CC, Fehm TN, Fasching PA. Beierlein M, et al. Among authors: sutterlin mw. Int J Cancer. 2025 Dec 1;157(11):2363-2373. doi: 10.1002/ijc.70037. Epub 2025 Jul 11. Int J Cancer. 2025. PMID: 40641449 Free PMC article. Clinical Trial.
Accelerated Partial Breast Irradiation in Clinical Practice.
Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, Gauter-Fleckenstein B, Vaidya JS, Sütterlin M. Wenz F, et al. Among authors: sutterlin m. Breast Care (Basel). 2015 Aug;10(4):247-52. doi: 10.1159/000437194. Epub 2015 Jul 15. Breast Care (Basel). 2015. PMID: 26600760 Free PMC article. Review.
Laparoscopic Fertility-Sparing Surgery for Early Ovarian Malignancies.
Zimmermann JSM, Ramisch P, Radosa MP, Radosa CG, Kaya AC, Brucker SY, Taran FA, Ulrich UA, Hackethal A, Deeken M, Sütterlin M, Tuschy B, Solomayer EF, Radosa JC. Zimmermann JSM, et al. Among authors: sutterlin m. Cancers (Basel). 2023 Oct 22;15(20):5099. doi: 10.3390/cancers15205099. Cancers (Basel). 2023. PMID: 37894466 Free PMC article.
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.
Krieghoff-Henning E, Michaeli T, Boch T, Kirchhof J, Haselmann V, Neumaier M, Hofmann WK, Betge J, Ebert M, Teufel A, Ast V, Sauer C, Cotarelo C, Lozynskyy R, Janning M, Marmé F, Sütterlin M, Streuer A, Siegel F, Brochhausen C, Collienne M, Nowak D, Loges S. Krieghoff-Henning E, et al. Among authors: sutterlin m. ESMO Open. 2025 Dec;10(12):105894. doi: 10.1016/j.esmoop.2025.105894. Epub 2025 Nov 25. ESMO Open. 2025. PMID: 41297163 Free PMC article.
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.
Sperk E, Lemanski C, Neumaier C, Lauer J, Siefert V, Völker R, Lindner C, Niehoff P, Tallet AR, Racadot S, Petit A, Pazos M, Le-Blanc Onfroy M, Martin E, Reuter C, Hermann RM, Pohl F, Friedrichs K, Würschmidt F, Pigorsch S, Kolberg HC, Graf H, Brunner TB, Malter W, Park-Simon TW, Brucker C, Fleckenstein J, Petersen C, Tuschy B, Wilken EE, Büttner S, Sütterlin M, Flyger H, Wenz F. Sperk E, et al. Among authors: sutterlin m. BMC Cancer. 2025 Dec 4;25(1):1862. doi: 10.1186/s12885-025-15289-0. BMC Cancer. 2025. PMID: 41345599 Free PMC article. Clinical Trial.
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer.
Saini M, Schmidleitner L, Moreno HD, Donato E, Falcone M, Bartsch JM, Klein C, Vogel V, Würth R, Pfarr N, Espinet E, Lehmann M, Königshoff M, Reitberger M, Haas S, Graf E, Schwarzmayr T, Strom TM, Spaich S, Sütterlin M, Schneeweiss A, Weichert W, Schotta G, Reichert M, Aceto N, Sprick MR, Trumpp A, Scheel CH. Saini M, et al. Among authors: sutterlin m. Cell Rep. 2023 Jun 27;42(6):112533. doi: 10.1016/j.celrep.2023.112533. Epub 2023 May 30. Cell Rep. 2023. PMID: 37257449 Free article.
204 results